Pharma Group Gets $75M To Further Cancer Drug Research
A life sciences group that recently partnered with Mount Sinai to work on a drug for the coronavirus said Thursday it's closed on $75 million from investors to continue researching treatments...To view the full article, register now.
Already a subscriber? Click here to view full article